Full Story
Neuralink, the brain-computer interface company founded by Elon Musk, has successfully implanted its brain chip in a second human trial participant. This milestone represents a major advancement in Neuralink’s mission to merge technology with human cognition.
The chip, designed to enable direct communication between the brain and external devices, holds immense potential for treating neurological disorders and enhancing human capabilities. Neuralink’s ultimate vision includes restoring motor function in paralyzed individuals, treating conditions like Parkinson's disease, and enabling seamless integration between humans and artificial intelligence
